NPR on Instagram: "Federal regulators have approved a pill version of the popular weight loss drug Wegovy, which is currently only available as an injection. The pills could hit the market by early next year.⁠ ⁠ Meanwhile, injectable GLP-1 weight loss drugs have transformed obesity care, but they don’t work for everyone.⁠ ⁠ Roughly half of those who take GLP1s lose 15% or more of their bodyweight, but a minority — about one in six — lose very little. Doctors specializing in obesity care say this

Evolving AI on Instagram: "What a crazy crossover. This AI generated video by @ai_daniels blends familiar film worlds into a single short story without actors, sets, or a traditional production crew. What stands out is how complete it feels as a piece of filmmaking. It lowers the barrier for who gets to create at a high level, while also raising real questions around IP, likeness, and what originality means when characters and styles can be generated on demand. This is not the end of Hollywood.